FDA ALERT
FDA ALERT
11/08/2015
Anthony Calabro, MA
The FDA approved ustekinumab-auub as an interchangeable biosimilar with ustekinumab for multiple inflammatory diseases.
11/08/2015
FDA ALERT
FDA ALERT
11/08/2015
Anthony Calabro, MA
The FDA approved ustekinumab-auub as an interchangeable biosimilar with ustekinumab for multiple inflammatory diseases.
11/08/2015
Public Health
Public Health
10/30/2015
Miranda Manier, BA
The CDC has updated its guidelines for COVID-19 and pneumococcal vaccines, aiming to boost protection for high-risk populations against severe disease year-round.
10/30/2015
Public Health
Public Health
12/15/2014
Children younger than 2 years who were born prematurely are at increased risk of being hospitalized if they develop influenza, according to a new systematic review and meta-analysis.
12/15/2014
health outcomes
health outcomes
02/24/2011
The COVID-19 pandemic disrupted all facets of health care. In a recent study, researchers examined how COVID-19-related health care delays have affected the treatment of hepatitis C virus, and how these...
02/24/2011